WHO's 2 new medicines to treat Covid-19 amid Omicron
WHO's 2 new medicines to treat Covid-19 amid Omicron
Share:

The World Health Organization (WHO) last Friday recommended two new medications for the treatment of Covid-19 amid rising cases of corona's new omicron variant. Yes, and these two new medicines are Baricitinib and Casirivimab-Imdevimab. In fact, in a recent statement issued by health body experts in the peer review journal BMJ, experts said, "Baricitinib can be used with corticosteroids to treat critically ill patients. This medicine is commonly used in the treatment of arthritis.''

In fact, WHO has said, "This medicine reduces the need for ventilators and can reduce the risk of the patient's life without any side effects. It has the same effect as another arthritis drug, Interleukin-6 (IL-6). If you have options for both medicines, buy the medicine based on price, availability and technician experience. Don't make the mistake of taking both medicines at a time.'' In addition, WHO in this guideline update has also recommended the use of monoclonal antibody sotrovimab keeping in view the situation. He says it can be given to patients with less serious infections, but more at risk of hospitalization.

At the same time, WHO has made a similar recommendation for another monoclonal antibody drug Casirivimab-Imdivimeb. In addition, a statement issued by the WHO said, "There was not enough data available to recommend monoclonal antibody treatment and the health body also admitted that its effectiveness against new variants like omicrons is not known at present. The guidelines will be updated as soon as adequate data of monoclonal antibodies is received.''

Let me tell all of you that these recommendations of the WHO are based on the evidence found in seven trials on 4,000 normal, less serious and more serious infected patients. In fact, all these patients are part of a living guideline developed by WHO in association with the Methodological Support of Magic Evidence Ecosystem Foundation. So that guidelines can be given for covid-19 management and doctors treating patients can also take better decisions.

Pakistan releases its first-ever national security policy, Know what's special

Sri Lanka's economy is expected to grow by 5.5% in 2022: Reports

British GDP surpasses pre-pandemic levels, Peek inside

Join NewsTrack Whatsapp group
Related News